8-K: Onconetix Stockholders Approve Reverse Stock Split to Boost Share Price and Maintain Nasdaq Listing

Onconetix, Inc. announced that its stockholders have approved a reverse stock split at a ratio between 1-for-10 and 1-for-150, aimed at increasing its per-share price and maintaining Nasdaq compliance.

Summary

• On May 30, 2025, Onconetix, Inc. held its 2025 special meeting of stockholders.
• Stockholders approved an amendment to the company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its common stock.
• The approved reverse stock split ratio is in the range of 1-for-10 to 1-for-150, with the exact ratio to be determined by the Board of Directors without further stockholder approval.
• The reverse stock split can be implemented at any time prior to the one-year anniversary date of the Special Meeting.
• The Adjournment Proposal, allowing for the meeting to be adjourned if necessary to solicit additional proxies, was also approved.
• As of the record date of April 14, 2025, there were 44,358,422 shares of Common Stock outstanding.
• The Reverse Stock Split Proposal received 11,956,279 votes For, 4,222,940 votes Against, and 153,929 Abstentions.
• The Adjournment Proposal received 13,570,278 votes For, 2,367,590 votes Against, and 395,280 Abstentions.

Sentiment

Score: 4

Explanation: While the approval of the reverse stock split provides Onconetix with a mechanism to address its low share price and maintain Nasdaq listing, the necessity of such an action typically reflects underlying challenges with the company's valuation or market perception. The action itself is a procedural step to avoid delisting, rather than an indicator of improved fundamental performance.

Positives

• Stockholder approval of the reverse stock split provides the company with a mechanism to potentially increase its per-share price, which is crucial for meeting minimum bid price requirements for continued listing on The Nasdaq Stock Market LLC.
• The approval of the Adjournment Proposal provides the company with flexibility to ensure sufficient votes for future proposals if needed.

Negatives

• The necessity of a reverse stock split often indicates a significantly low stock price, which can be perceived as a negative signal regarding the company's financial health or market perception.
• While a reverse split increases the per-share price, it does not change the company's underlying market capitalization or fundamental value, and there is no guarantee of sustained price improvement.

Risks

• The reverse stock split is typically implemented to meet minimum bid price requirements for continued listing on The Nasdaq Stock Market LLC, indicating a current challenge with maintaining compliance.
• There is a risk that the reverse stock split may not lead to a sustained increase in the per-share price, potentially requiring further actions or leading to delisting if compliance is not achieved.
• Investor perception of reverse stock splits can be negative, potentially leading to continued downward pressure on the stock price post-split.

Future Outlook

The Board of Directors has been granted the authority to determine the exact ratio for the reverse stock split, ranging from 1-for-10 to 1-for-150, and can implement this action at any time prior to the one-year anniversary of the Special Meeting, indicating the company's intent to address its share price and maintain exchange listing.

Management Comments

• The report was signed by Karina M. Fedasz, Interim Chief Executive Officer and Interim Chief Financial Officer.

Industry Context

Reverse stock splits are a common strategy employed by companies, particularly those in the biotechnology or emerging growth sectors, to increase their per-share stock price to meet minimum bid price requirements of major stock exchanges like Nasdaq. This action is often a response to sustained low stock prices, which can be a symptom of broader market challenges or company-specific performance issues within the industry.

Corporate Governance

Stakeholder Impact

• Shareholders: Will experience a reduction in the number of shares they own, with a proportional increase in the per-share price, but no immediate change in the total value of their holdings. The action aims to preserve Nasdaq listing, which benefits shareholders by maintaining liquidity and visibility.
• Nasdaq Stock Market LLC: The action is intended to help Onconetix comply with listing requirements, benefiting the exchange by maintaining the integrity of its listed companies.

Next Steps

• The Board of Directors will determine the specific ratio for the reverse stock split within the approved range of 1-for-10 to 1-for-150.
• The company plans to effect the reverse stock split at any time prior to May 30, 2026.

Key Dates

Keywords

Onconetix, ONCO, Reverse Stock Split, Stockholder Meeting, Nasdaq Listing, Corporate Governance, SEC Filing, 8-K, Share Price, Delisting Risk